FRANKLIN RESOURCES INC - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 131 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$24,582,000
+14.0%
1,641,004
-7.4%
0.01%
+18.2%
Q1 2016$21,571,000
-54.7%
1,772,444
-40.7%
0.01%
-54.2%
Q4 2015$47,566,000
-20.3%
2,989,568
-23.2%
0.02%
-17.2%
Q3 2015$59,665,000
-41.2%
3,891,957
-6.7%
0.03%
-37.0%
Q2 2015$101,463,000
+9.4%
4,173,680
+4.6%
0.05%
+9.5%
Q1 2015$92,744,000
-16.3%
3,989,011
-9.6%
0.04%
-16.0%
Q4 2014$110,807,000
-37.4%
4,412,832
-22.4%
0.05%
-38.3%
Q3 2014$176,899,000
+8.2%
5,688,153
-10.0%
0.08%
+12.5%
Q2 2014$163,440,000
+22.7%
6,320,293
+10.9%
0.07%
+14.3%
Q1 2014$133,232,000
+16.1%
5,701,029
+26.1%
0.06%
+12.5%
Q4 2013$114,718,000
+42.4%
4,520,018
+14.4%
0.06%
+30.2%
Q3 2013$80,586,0003,950,3370.04%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders